Combining artificial intelligence and nanoscale sensors, the research demonstrates a new approach that could potentially detect and distinguish different types of brain tumors

DUBAI, RIYADH, DOHA 19 January 2026 – Researchers at Memorial Sloan Kettering Cancer Center (MSK) have developed an ultrasensitive diagnostic test that could change how brain tumors are detected, offering a less invasive alternative to surgery and the potential for faster diagnosis. The research, led by an MSK cancer engineering laboratory, demonstrated that the test was able to detect and classify different types of brain tumors with up to 98% accuracy in early studies.